Abstract
The Jan Vishwas (Amendment of Provisions) Bill 2026, approved by the Lok Sabha on April 1, 2026, marks a sweeping shift away from India's colonial-era legacy of regulatory overcriminalization. For decades, minor compliance lapses like typos and paperwork errors carried severe prison threats, creating an atmosphere of fear that heavily burdened entrepreneurs and small businesses. Expanding drastically on its 2023 predecessor, the 2026 Bill amends 784 sections across 79 statutes, completely removing or shifting criminal punishments in 717 provisions to align governance with the constitutional principle of proportionality. It establishes a graded enforcement framework where warnings and improvement notices replace immediate jail terms for minor infractions, backed by an administrative adjudication mechanism designed to resolve disputes outside of backlogged courts. Additionally, to ensure penalties maintain their deterrent value against inflation, the Bill introduces an automatic 10% increase in fines every three years.
However, the legislation faces notable structural criticism from observers who argue that certain decriminalization choices lack transparent public-harm criteria and may favour corporate interests. Public health experts are particularly concerned about updates to the Drugs and Cosmetics Act, where swapping prison sentences for fines for manufacturing poor-quality medicines risks shifting safety dangers directly onto consumers. Critics also flag the removal of postal safeguards that historically protected citizens' mail integrity. Ultimately, while the Bill successfully reimagines businesses as development collaborators rather than presumed offenders, its long-term impact will depend heavily on robust real-world implementation, adequate funding, and the institutional strength of its new quasi-judicial bodies.